2,932 followers
RT @SpringerUrology: A phase 3, open-label, multicenter study of a 6-month pre-mixed depot formulation of leuprolide mesylate in advanced p…
RT @SpringerUrology: A phase 3, open-label, multicenter study of a 6-month pre-mixed depot formulation of leuprolide mesylate in advanced p…
A phase 3, open-label, multicenter study of a 6-month pre-mixed depot formulation of leuprolide mesylate in advanced prostate cancer patients https://t.co/mb5jP5ee79 via @wjurol #OpenAccess